Trial Profile
Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Investigate the Analgesic Effect of OROS Hydromorphone Hydrochloride in Comparison With Placebo in Subjects With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Acronyms HOP
- Sponsors Janssen-Cilag
- 25 Sep 2009 New trial record